Without a host, viruses are nothing. The Sars-CoV-2 coronavirus has been known to harbour humans for some time. In order to multiply, it hijacks the cells of our body and introduces its genetic material. Using the genetic blueprint, the body cell then produces virus copies. Without this mechanism, the virus perishes.
Researchers at the University of Texas have now decoded the three-dimensional structure of a viral enzyme. It enables the pathogen to evade the immune system when entering the body cells. The scientists hope that the new findings will help them to find effective drugs against the virus, they report in the journal "Nature Communications".
Structural basis of RNA cap modification by SARS-CoV-2
Quote:Abstract
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causative agent of COVID-19 illness, has caused millions of infections worldwide. In SARS coronaviruses, the non-structural protein 16 (nsp16), in conjunction with nsp10, methylates the 5′-end of virally encoded mRNAs to mimic cellular mRNAs, thus protecting the virus from host innate immune restriction. We report here the high-resolution structure of a ternary complex of SARS-CoV-2 nsp16 and nsp10 in the presence of cognate RNA substrate analogue and methyl donor, S-adenosyl methionine (SAM). The nsp16/nsp10 heterodimer is captured in the act of 2′-O methylation of the ribose sugar of the first nucleotide of SARS-CoV-2 mRNA. We observe large conformational changes associated with substrate binding as the enzyme transitions from a binary to a ternary state. This induced fit model provides mechanistic insights into the 2′-O methylation of the viral mRNA cap. We also discover a distant (25 Å) ligand-binding site unique to SARS-CoV-2, which can alternatively be targeted, in addition to RNA cap and SAM pockets, for antiviral development.
... ... ... ... ...